Trevena Inc (TRVN)

Will Trevena Continue to Surge Higher? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Wainwright cuts Trevena stock target, maintains Buy rating - Investing.com South Africa

Investing.com South Africa

Wainwright cuts Trevena stock target, maintains Buy rating - Investing.com Canada

Investing.com Canada

Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com - Defense World

Defense World

Trevena Inc. Under Fire: Unregistered Equity Sales Risk Legal Woes and Market Trust - TipRanks.com - TipRanks

TipRanks

Trevena Reports Progress in Pain and Epilepsy Treatment Development, Amid Financial Adjustments - MyChesCo

MyChesCo

Trevena's NDA for Pain Drug Oliceridine Gets FDA Acceptance - Yahoo News Australia

Yahoo News Australia

Industry faces next wave of layoffs: Bolt, Biomarin making cuts - BioWorld Online

BioWorld Online

Trevena Inc expected to post a loss of 47 cents a share - Earnings Preview - XM

XM

Postoperative Pain Therapeutics Service Market [2024-2031] | Mallinckrodt Pharmaceuticals, Trevena, Inc. - Motions Online

Motions Online

Trevena (NASDAQ:TRVN) Research Coverage Started at StockNews.com - Defense World

Defense World

Trevena (NASDAQ:TRVN) Stock Crosses Below 200 Day Moving Average of $0.56 - Defense World

Defense World

Apellis (APLS) Up on Tie-up With Beam for Novel Therapies - Yahoo Movies Canada

Yahoo Movies Canada

Trevena Ramps Up Efforts on TRV045, Turns Attention Away from OLINVYK Amid Challenging Hospital Environment - MyChesCo

MyChesCo

Trevena Inc Unveils Updated Corporate Strategy Presentation - TipRanks.com - TipRanks

TipRanks

Trevena: Q4 Earnings Snapshot - Quartz

Quartz

Trevena faces Nasdaq delisting over share price By Investing.com - Investing.com

Investing.com

CustomerInsights.AI Announces Strategic Advisory Board Members for 2024 - PR Newswire

PR Newswire

Opioid Use Disorder Treatment Market Targets US$ 8.4 Billion by 2033, Fueled by Buprenorphine's 81.4 - PharmiWeb.com

PharmiWeb.com

Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise

GlobeNewswire Inc.

Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise

GlobeNewswire Inc.

Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting

GlobeNewswire Inc.

Trevena Awarded OLINVYK Agreement with Premier, Inc.

GlobeNewswire Inc.

Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Benzinga

Trevena Appoints Mark Corrigan, M.D. to Board of Directors - citybiz

citybiz

Oliceridine Presents Low Risk for Opioid-Induced Respiratory Depression - Anesthesiology News

Anesthesiology News

Lab Notes: Trevena receives $3M payment; Wayne firm raises $7.2M - The Business Journals

The Business Journals

Jiangsu Nhwa receives China's NMPA approval for Olinvyk - Pharmaceutical Technology

Pharmaceutical Technology

Trevena (TRVN) Initiates Proof-of-Concept for Epilepsy Candidate - Yahoo Movies Canada

Yahoo Movies Canada

Rich Insights into the Opioid Dependence Clinical Trial Analysis Featuring 25+ Companies and Therapies | DelveInsight - GlobeNewswire

GlobeNewswire

Keaton Trevena Obituary (2022) - Tampa, FL - Cremations of Greater Tampa Bay, Inc. - Tampa - Legacy.com

Legacy.com

Trevena lays off 25% of its staff in a low-key restructure - FiercePharma

FiercePharma

Rockwell Medical Appoints Mark Strobeck, Ph.D., as CEO - citybiz

citybiz

Lab Notes: AmerisourceBergen teams with UK tech firm; Chimeron Bio relocates to Center City - The Business Journals

The Business Journals

Trevena Inc. (NASDAQ: TRVN) Reports Q3 2021 Net Loss of $13.9 Million It Advances OLINVYK To Commercial Launch - BP Journal

BP Journal

Postoperative Pain Market to Rising Steadily at a 7.93% CAGR Owing to Growing Number of Surgeries, During the ... - PR Newswire

PR Newswire

Geron (GERN) Soars on Imetelstat Data for Myelofibrosis - Yahoo Finance

Yahoo Finance

Trevena's OLINVYK Provides Compelling Growth Profile (NASDAQ:TRVN) - Seeking Alpha

Seeking Alpha

Vanessa Hudgens Teams Up with BFF Oliver Trevena to Launch Caliwater!: Photo 4547007 | Oliver Trevena, Vanessa ... - Just Jared

Just Jared

Vanessa Hudgens Is Launching a New Beverage Company With Oliver Trevena - Just Jared Jr.

Just Jared Jr.

Trevena: Reaffirming A Buy On OLINVYK DEA Scheduling (NASDAQ:TRVN) - Seeking Alpha

Seeking Alpha

Navy Yard returns to its roots while some Philly start-ups depart for the suburbs - The Philadelphia Inquirer

The Philadelphia Inquirer

OLINVYK (oliceridine) for the Treatment of Acute Pain - Clinical Trials Arena

Clinical Trials Arena

Trevena soars as it gains FDA approval for Olinvyk - The Pharma Letter

The Pharma Letter

Trevena (TRVN) Just Days Away From FDA Decision - RTTNews

RTTNews

Trevena Inc.'s (NASDAQ:TRVN) Chinese Partner Receives Oluceridine Approval As The company Announces ... - BP Journal

BP Journal

Daily Earnings Surprises - Nasdaq

Nasdaq

3 Biotech Stocks Under $2 With Massive Upside Potential - Yahoo Finance

Yahoo Finance

Trevena resubmits new drug application to USFDA for Oliceridine - Clinical Trials Arena

Clinical Trials Arena

Will Trevena Continue to Surge Higher? - Yahoo Lifestyle UK

Yahoo Lifestyle UK